Download presentation
Published byVivien Cox Modified over 9 years ago
1
How antipsychotics work: Attaching to receptors and changing reality
Shitij Kapur Institute of Psychiatry, King’s College London
2
Outline What is ‘psychosis’ A short introduction to a patient
Before we had effective medications How they came about How they work
3
Lets meet …
4
Antipsychotic treatments prior to 1951
The whirling chair Insulin Coma Artificial Hibernation
5
Radical new treatments for Schizophrenia
RP 4560 aka CHLORPROMAZINE ‘Largactil’ 1950s 5
6
But, how do they work … 6
7
PET neuroreceptor imaging
Cyclotron 11C synthesis Radio-pharmaco-chemistry 11C- raclopride synthesis PET Imaging after 11C- raclopride injection Image Reconstruction Measures of interest Modeling of the TACs Dynamic Time Activity Curves Region of Interest D2 receptors [1.5 or 15 pmol/ml] Ratio method Analytic models 50% Occupancy
9
Antipsychotics and D2 Occupancy
11C-Raclopride PET Scan 11C-Raclopride PET Scan Coregistered MRI Scan Before Treatment Haloperidol 2 mg/d (74% Occ.) Farde – Karolinska, Wong – Hopkins, Others and Kapur Lab 1990s
10
D2 occupancy predicts clinical response
D2 occupancy predicts response on CGI (p < 0.001) Predicts change in positive symptoms PANSS (p = 0.07) Kapur et al. Am. J Psychiatry, 2000
11
D2 occupancy predicts EPS/akathisia
Subjects with EPS or akathisia 78% NO subject < 78% showed EPS/akathisia Kapur et al. American Journal of Psychiatry, 2000.
12
Good for science, but, does it make a difference for patients….
13
Knowledge of occupancy data has lead to lower dose recommendations.
Data from Kapur et al. Psychopharmacology (131): , 1998.
14
What we know and what we don’t
What we know now That antipsychotics act on the dopamine D2 receptor That you need to block a certain threshold ~ 60% That if you block too many, you get side-effects What we still don’t know Why do some patients not get better even though we do block the receptors? Why does blocking a receptor change your ideas?
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.